Coagulation Factor IX Human
- Generic Name
- Coagulation Factor IX Human
- Brand Names
- Alphanine Sd, Balfaxar, Beriplex, Immunine Vh, Kcentra, Octaplex
- Drug Type
- Biotech
- CAS Number
- 181054-95-5
- Unique Ingredient Identifier
- 6U90Y1795T
- Background
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
- Indication
Factor IX is used to treat Christmas disease. Factor IX deficiency is treated by injection factor IX produced from human plasma. Tranexamic acid may be of value in patients undergoing surgery who have inherited factor IX deficiency in order to reduce the perioperative risk of bleeding.
- Associated Conditions
- Acquired Coagulation Factor Deficiency, Bleeding caused by Hemophilia B, Major Bleeding, Vitamin K antagonist induced major bleeding
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Tulane University
- Target Recruit Count
- 12
- Registration Number
- NCT05281718
- Locations
- 🇺🇸
Tulane University Lakeside Hospital and Clinics, Metairie, Louisiana, United States
🇺🇸University Medical Center New Orleans, New Orleans, Louisiana, United States
Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2007-08-30
- Lead Sponsor
- Prothya Biosolutions
- Target Recruit Count
- 12
- Registration Number
- NCT00139828
- Locations
- 🇳🇱
Erasmus Medical Centre, Rotterdam, Netherlands
🇳🇱Leyenburg Hospital, The Hague, Netherlands
🇳🇱Van Creveldkliniek, Utrecht, Netherlands
Cooperative Study of Factor VIII Inhibitors
- Conditions
- Blood Coagulation DisordersHematologic DiseasesHemophilia AHemorrhagic Disorders
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.